Health Canada Permits the Use of Glaukos iStent Inject
Monday, August 17 2015 | 00 h 00 min | Latest News
Health Canada has approved the use of the iStent inject® Trabecular Micro-Bypass for the reduction of intraocular pressure in patients with glaucoma.
Distributed in Canada by Labtician Ophthalmics, this system has been approved for patients diagnosed with primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma.
The iStent inject can be used in conjunction with cataract surgery for patients requiring IOP reduction or who would benefit from a reduction in glaucoma medication.
The iStent inject system comes with an injector preloaded with two stents, which allows an ophthalmic surgeon to position two stents through a single opening in the cornea for greater IOP reduction. Each stent is 0.3 mm in diameter and 0.4 mm long.
Further information: http://www.businesswire.com/news/home/20150810005341/en/Health-Canada-Approves-Glaukos-iStent-inject
